North America Antivenom Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Publisher Name :
Date: 12-Apr-2018
No. of pages: 118

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Scope of the Report:

This report focuses on the Antivenom in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

- CSL Behring

- Merck & Co., Inc.

- BTG Plc

- Pfizer

- Haffkine Bio-Pharmaceutical Corporation

- Rare Disease Therapeutics

- Flynn Pharma

- Vins Bioproducts

- Bharat Serums and Vaccines

- Serum Biotech

Market Segment by Countries, covering

- United States

- Canada

- Mexico

Market Segment by Type, covers

- Polyvalent antivenom

- Monovalent antivenom

Market Segment by Applications, can be divided into

- Retail Pharmacies

- Hospitals

- Others

There are 15 Chapters to deeply display the North America Antivenom market.

Chapter 1, to describe Antivenom Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Antivenom, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Antivenom, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Antivenom market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Antivenom Research Findings and Conclusion, Appendix, methodology and data source

North America Antivenom Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Antivenom Introduction
1.2 Market Analysis by Type
1.2.1 Polyvalent antivenom
1.2.2 Monovalent antivenom
1.3 Market Analysis by Applications
1.3.1 Retail Pharmacies
1.3.2 Hospitals
1.3.3 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Profile
2.1.2 Antivenom Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 CSL Behring News
2.2 Merck & Co., Inc.
2.2.1 Profile
2.2.2 Antivenom Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merck & Co., Inc. News
2.3 BTG Plc
2.3.1 Profile
2.3.2 Antivenom Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 BTG Plc News
2.4 Pfizer
2.4.1 Profile
2.4.2 Antivenom Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Pfizer News
2.5 Haffkine Bio-Pharmaceutical Corporation
2.5.1 Profile
2.5.2 Antivenom Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Haffkine Bio-Pharmaceutical Corporation News
2.6 Rare Disease Therapeutics
2.6.1 Profile
2.6.2 Antivenom Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Rare Disease Therapeutics News
2.7 Flynn Pharma
2.7.1 Profile
2.7.2 Antivenom Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Flynn Pharma News
2.8 Vins Bioproducts
2.8.1 Profile
2.8.2 Antivenom Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Vins Bioproducts News
2.9 Bharat Serums and Vaccines
2.9.1 Profile
2.9.2 Antivenom Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Bharat Serums and Vaccines News
2.10 Serum Biotech
2.10.1 Profile
2.10.2 Antivenom Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Serum Biotech News
3 North America Antivenom Market Competition, by Manufacturer
3.1 North America Antivenom Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Antivenom Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Antivenom Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Antivenom Manufacturer Market Share
3.4.2 Top 5 Antivenom Manufacturer Market Share
3.5 Market Competition Trend
4 North America Antivenom Market Analysis by Countries
4.1 North America Antivenom Sales Market Share by Countries
4.2 North America Antivenom Sales by Countries (2012-2017)
4.3 North America Antivenom Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Antivenom by Type
5.1 North America Antivenom Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Antivenom Sales and Market Share by Type (2012-2017)
5.1.2 North America Antivenom Revenue and Market Share by Type (2012-2017)
5.2 Polyvalent antivenom Sales Growth and Price
5.2.1 North America Polyvalent antivenom Sales Growth (2012-2017)
5.2.2 North America Polyvalent antivenom Price (2012-2017)
5.3 Monovalent antivenom Sales Growth and Price
5.3.1 North America Monovalent antivenom Sales Growth (2012-2017)
5.3.2 North America Monovalent antivenom Price (2012-2017)
6 North America Market Segmentation Antivenom by Application
6.1 North America Antivenom Sales Market Share by Application (2012-2017)
6.2 Retail Pharmacies Sales Growth (2012-2017)
6.3 Hospitals Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)
7 United States Antivenom Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Antivenom Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Antivenom Sales and Market Share by Type
7.3 United States Antivenom Sales by Application (2012-2017)
7.4 United States Antivenom Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Antivenom Sales and Market Share by Manufacturer
7.4.2 United States Antivenom Revenue and Market Share by Manufacturer
7.5 United States Antivenom Export and Import (2012-2017)
8 Canada Antivenom Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Antivenom Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Antivenom Sales and Market Share by Type
8.3 Canada Antivenom Sales by Application (2012-2017)
8.4 Canada Antivenom Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Antivenom Sales and Market Share by Manufacturer
8.4.2 Canada Antivenom Revenue and Market Share by Manufacturer
8.5 Canada Antivenom Export and Import (2012-2017)
9 Mexico Antivenom Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Antivenom Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Antivenom Sales and Market Share by Type
9.3 Mexico Antivenom Sales by Application (2012-2017)
9.4 Mexico Antivenom Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Antivenom Sales and Market Share by Manufacturer
9.4.2 Mexico Antivenom Revenue and Market Share by Manufacturer
9.5 Mexico Antivenom Export and Import (2012-2017)
10 Antivenom Market Forecast (2017-2022)
10.1 North America Antivenom Sales, Revenue and Growth Rate (2017-2022)
10.2 Antivenom Market Forecast by Countries (2017-2022)
10.2.1 United States Antivenom Forecast (2017-2022)
10.2.2 Canada Antivenom Forecast (2017-2022)
10.2.3 Mexico Antivenom Forecast (2017-2022)
10.3 Antivenom Market Forecast by Type (2017-2022)
10.4 Antivenom Market Forecast by Application (2017-2022)
11 Antivenom Manufacturing Cost Analysis
11.1 Antivenom Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antivenom
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Antivenom Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antivenom Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Antivenom Picture
Table Product Specifications of Antivenom
Figure North America Sales Market Share of Antivenom by Types in 2016
Table Types of Antivenom
Figure Polyvalent antivenom Picture
Table Major Manufacturers of Polyvalent antivenom
Figure Monovalent antivenom Picture
Table Major Manufacturers of Monovalent antivenom
Table North America Antivenom Sales Market Share by Applications in 2016
Table Applications of Antivenom
Figure Retail Pharmacies Picture
Figure Hospitals Picture
Figure Others Picture
Figure United States Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Antivenom Type and Applications
Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Antivenom Type and Applications
Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Plc Basic Information, Manufacturing Base and Competitors
Table BTG Plc Antivenom Type and Applications
Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antivenom Type and Applications
Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Type and Applications
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table Rare Disease Therapeutics Antivenom Type and Applications
Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table Flynn Pharma Antivenom Type and Applications
Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table Vins Bioproducts Antivenom Type and Applications
Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table Bharat Serums and Vaccines Antivenom Type and Applications
Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Biotech Basic Information, Manufacturing Base and Competitors
Table Serum Biotech Antivenom Type and Applications
Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Antivenom Sales by Manufacturer (2016-2017)
Figure North America Antivenom Sales Market Share by Manufacturer in 2016
Figure North America Antivenom Sales Market Share by Manufacturer in 2017
Table North America Antivenom Revenue by Manufacturer (2016-2017)
Figure North America Antivenom Revenue Market Share by Manufacturer in 2016
Figure North America Antivenom Revenue Market Share by Manufacturer in 2017
Table North America Antivenom Price by Manufacturers (2016-2017)
Figure Top 3 Antivenom Manufacturer Market Share in 2016
Figure Top 3 Antivenom Manufacturer Market Share in 2017
Figure Top 5 Antivenom Manufacturer Market Share in 2016
Figure Top 5 Antivenom Manufacturer Market Share in 2017
Figure North America Antivenom Sales and Growth (2012-2017)
Table North America Antivenom Sales by Countries (2012-2017)
Table North America Antivenom Sales Market Share by Countries (2012-2017)
Figure North America 2012 Antivenom Sales Market Share by Countries
Figure North America 2016 Antivenom Sales Market Share by Countries
Figure North America Antivenom Revenue and Growth (2012-2017)
Table North America Antivenom Revenue by Countries (2012-2017)
Table North America Antivenom Revenue Market Share by Countries (2012-2017)
Table North America 2012 Antivenom Revenue Market Share by Countries
Table North America 2016 Antivenom Revenue Market Share by Countries
Table North America Antivenom Sales by Type (2012-2017)
Table North America Antivenom Sales Share by Type (2012-2017)
Table North America Antivenom Revenue by Type (2012-2017)
Table North America Antivenom Revenue Share by Type (2012-2017)
Figure North America Polyvalent antivenom Sales Growth (2012-2017)
Figure North America Polyvalent antivenom Price (2012-2017)
Figure North America Monovalent antivenom Sales Growth (2012-2017)
Figure North America Monovalent antivenom Price (2012-2017)
Table North America Antivenom Sales by Application (2012-2017)
Table North America Antivenom Sales Share by Application (2012-2017)
Figure North America Retail Pharmacies Sales Growth (2012-2017)
Figure North America Hospitals Sales Growth (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure United States Antivenom Revenue and Growth (2012-2017)
Figure United States Antivenom Sales and Growth (2012-2017)
Table United States Antivenom Sales by Type (2012-2017)
Table United States Antivenom Sales Market Share by Type (2012-2017)
Table United States Antivenom Sales by Application (2012-2017)
Table United States Antivenom Sales Market Share by Application (2012-2017)
Table United States Antivenom Sales by Manufacturer (2016-2017)
Figure United States Antivenom Sales Market Share by Manufacturer in 2016
Figure United States Antivenom Sales Market Share by Manufacturer in 2017
Table United States Antivenom Revenue by Manufacturer (2016-2017)
Figure United States Antivenom Revenue Market Share by Manufacturer in 2016
Figure United States Antivenom Revenue Market Share by Manufacturer in 2017
Table United States Antivenom Export and Import (2012-2017)
Figure Canada Antivenom Revenue and Growth (2012-2017)
Figure Canada Antivenom Sales and Growth (2012-2017)
Table Canada Antivenom Sales by Type (2012-2017)
Table Canada Antivenom Sales Market Share by Type (2012-2017)
Table Canada Antivenom Sales by Application (2012-2017)
Table Canada Antivenom Sales Market Share by Application (2012-2017)
Table Canada Antivenom Sales by Manufacturer (2016-2017)
Figure Canada Antivenom Sales Market Share by Manufacturer in 2016
Figure Canada Antivenom Sales Market Share by Manufacturer in 2017
Table Canada Antivenom Revenue by Manufacturer (2016-2017)
Figure Canada Antivenom Revenue Market Share by Manufacturer in 2016
Figure Canada Antivenom Revenue Market Share by Manufacturer in 2017
Table Canada Antivenom Export and Import (2012-2017)
Figure Mexico Antivenom Revenue and Growth (2012-2017)
Figure Mexico Antivenom Sales and Growth (2012-2017)
Table Mexico Antivenom Sales by Type (2012-2017)
Table Mexico Antivenom Sales Market Share by Type (2012-2017)
Table Mexico Antivenom Sales by Application (2012-2017)
Table Mexico Antivenom Sales Market Share by Application (2012-2017)
Table Mexico Antivenom Sales by Manufacturer (2016-2017)
Figure Mexico Antivenom Sales Market Share by Manufacturer in 2016
Figure Mexico Antivenom Sales Market Share by Manufacturer in 2017
Table Mexico Antivenom Revenue by Manufacturer (2016-2017)
Figure Mexico Antivenom Revenue Market Share by Manufacturer in 2016
Figure Mexico Antivenom Revenue Market Share by Manufacturer in 2017
Table Mexico Antivenom Export and Import (2012-2017)
Figure North America Antivenom Sales, Revenue and Growth Rate (2017-2022)
Table North America Antivenom Sales Forecast by Countries (2017-2022)
Table North America Antivenom Market Share Forecast by Countries (2017-2022)
Figure United States Antivenom Sales Forecast (2017-2022)
Figure Canada Antivenom Sales Forecast (2017-2022)
Figure Mexico Antivenom Sales Forecast (2017-2022)
Table North America Antivenom Sales Forecast by Type (2017-2022)
Table North America Antivenom Market Share Forecast by Type (2017-2022)
Table North America Antivenom Sales Forecast by Application (2017-2022)
Table North America Antivenom Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivenom
Figure Manufacturing Process Analysis of Antivenom
Figure Antivenom Industrial Chain Analysis
Table Raw Materials Sources of Antivenom Major Manufacturers in 2016
Table Major Buyers of Antivenom
Table Distributors/Traders/ Dealers List
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Transforming Growth Factor Beta 1 Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is ......
  • Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler's diarrhea is the leading cause of illness among international tra......
  • Global Anticoagulant Drugs Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 31300 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoag......
  • Global OTC Herbal and Traditional Medicines Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 184
    Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease. Herbal medicine industry is dispersive relatively. Currently, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs